Tweet

 

Email

Email to a friend:

To:

Separate multiple addresses with commas.

From:

Name: Please send me a copy Message:

Verification code

Enter the code from aboveRequired

Send

ASIA

Nikkei gains for the third day on strong economic data from the US and China despite a technical glitch briefly halting trading, closing up 0.76%. (RTRS)

Honda – Co.’s January US vehicle sales rose 8.8% vs. Exp. down 1.2%. (Sources)

Toyota – Co.’s January US Toyota/Lexus vehicle sales rose 7.5% vs. Exp. up 7.0%. (Sources)

Top performing sectors in Nikkei 225: Telecommunications (+2.78%), Financials (+1.52%), Health Care (+1.20%)

Worst performing sectors in Nikkei 225: Utilities (-1.55%), Oil & Gas (-0.47%), Technology (+0.23%)

US

US equities finished the session in positive territory following some stronger PMI data from Germany, France, the UK and China. The US ISM Manufacturing release missed the whisper number but posted its best figure since June 2011, this added to the risk appetite as the S&P 500 approached its 2012 high of 1333. Today’s corporate earnings were relatively muted, with Hershey (+0.36%) one of the larger names reporting. Finally the DJIA finished up 0.66% at 12716.46, the S&P 500 finished up 0.89% at 1324.08 and the Nasdaq 100 finished up 0.82% at 2488.18.

Top performing sectors in S&P 500: Financials (+1.65%), Industrials (+1.12%), Basic Materials (+1.04%)

Worst performing sectors in S&P 500: Utilities (+0.40%), Oil & Gas (+0.45%), Consumer Services (+0.51%)           

Qualcomm – Co.’s Q1 adjusted EPS USD 0.97 vs. Exp. USD 0.90, co. boosts forecast, Q1 revenue USD 4.68bln vs. Exp. USD 4.57bln, co. sees Q2 adjusted revenue USD 4.6-5.0bln vs. Exp. USD 4.51bln, co. sees Q2 adjusted EPS 0.91-0.97 vs. Exp. USD 0.89, co. sees 2012 revenue USD 18.7-19.7bln, saw USD 18-19bln vs. Exp. USD 18.47bln, co. sees 2012 adjusted EPS USD 3.55-.375, saw USD 3.42-3.62 vs. Exp. USD 3.59, co. shares seen up 3.44% in after-market trade. (RTRS/Sources)

Electronic Arts – Co.’s Q3 adjusted EPS USD 0.99 vs. Exp. USD 0.93, Q3 non-gaap revenue USD 1.65bln vs. Exp. USD 1.62bln, co. sees Q4 adjusted revenue USD 1.65bln vs. Exp. USD 1.62bln, co. sees Q4 adjusted EPS USD 0.10-0.20 vs. Exp. USD 0.30, co. shares were seen down 4.6% in after-market trade. (RTRS)

Green Mountain Coffee – Co.’s Q1 adjusted EPS USD 0.60 vs. Exp. USD 0.36, co. reaffirms forecast, Q1 net sales USD 1.16bln, co. sees Q2 adjusted EPS USD 0.60-0.65 vs. Exp. USD 0.7, co. shares were seen up 11.7% in after-market trade. (RTRS)

Chipotle Mexican Grill – Co.’s Q4 EPS 1.81, revenue USD 596.7mln, shares seen down 3.9% in after-market trade. (RTRS)

Allstate – Co.’s Q4 operating EPS USD 1.48 vs. Exp. USD 0.96. (RTRS)

Facebook – Co. files its IPO under ‘FB’ symbol, with initial registration amount USD 5bln; via Morgan Stanley, JP Morgan and Goldman Sachs as their underwriters. Co. 2011 revenue USD 3.71bln vs. Exp. USD 1.97bln. The filing shows Zuckerberg owns 28.4% of the co., and Accel Entities 11.4%. (Sources)

ExxonMobil – Co. has started drilling for its USD 15.7bln Papua New Guinea gas project expansion. (Sources) 

Johnson & Johnson – Co. cancer drug Zytiga has been rejected for publicly funded use in the UK because the prostate-cancer pill does not offer value for money, according to the UK Healthcare regulator. (Sources)

UK

Xstrata – Co. confirms that is has received an approach from Glencore and is in discussions. Co. has added that there can be no certainty that any offer will be made. (RTRS)

Royal Dutch Shell - Co. Q4 CCS ex-items USD 4.8bln vs. Exp. USD 5.2bln, Q4 net income USD 6.5bln vs. Prev. 6.79bln. Says Q4 results impacted by sharp downturn in industry and says sees 250,000BOE/D of asset sales, expiries in 2012-17. Also says expects to grow the dividend in 2012. (RTRS/Sources)

AstraZeneca – Co. Q4 EPS ex-items USD 1.61 vs. Exp. USD 1.58. Co. Q4 revenue USD 8.66bln vs. Exp. USD 8.58bln. Co. Seroquel Q4 sales USD 1.55bln vs. Exp. USD 1.45bln. Co. has said it plans to buy back USD 4.5bln shares in 2012. Co. reports FY EPS ex-items USD 7.28 vs. Exp. USD 7.24 and has increased dividend by 10% to USD 2.80 for Full Year 2011. Co. cost cuts to affect 7,300 jobs and reaffirms planned revenue range of USD 28-34bln over 2010-2014.  (Sources)

GlaxoSmithKline – Co. agrees to settle 2,000 more Avandia cases due for trial in LA. (Sources)

Unilever - Co. Q4 underlying sales growth 6.6% v. Exp. 6.8%, FY net EUR 4.25bln vs. Exp. EUR 4.34bln. Says expects less input cost headwinds than in 2011. (RTRS/Sources)

BP – Co. is to call Transocean CEO to appear in person at the Deepwater Horizon trial. (FT-More)

RBS – Co. announced Jefferies agreed to acquire their Hoare Govett unit with the sale expected to complete by the end of Q1 2012, the Co. also said they remain in active talks with other parties over the sale of other units. (Sources)

Smith & Nephew - Q4 adjusted EPS GBP 0.219 vs. Exp. GBP 0.21, Q4 revenue USD 1.106bln vs. Exp. USD 1.11bln. Co. proposed Q4 final dividend up 10% to GBP 0.108 and says sees modest increase in 2012 trading profit margin. (RTRS/Sources)

Compass Group - Co. sticks to full-year forecast after "good" Q1. (RTRS/Sources)

FRANCE 

Vivendi – Co. announced a US South District court dismissed claims by shareholders who had bought ordinary shares on the Paris bourse. (Sources)

Axa Group – Co. will close the Hong Kong and Singapore operations of its unit Ipac Asia by the end of Q2. (Oriental Daily News)

GERMANY

Deutsche Bank – Co. Q4 net EUR 147mln vs. Exp. EUR 556mln. Co. CIB pretax loss EUR 138mln vs. Exp. EUR 526mln. Co. posts EUR 422mln loss at its investment banking arm in Q4. Co. reports core tier 1 capital ratio 9.5% at the end of Q4 and proposes dividend of EUR 0.75 for 2011 vs. Exp. EUR 0.75. Co. Q4 loan-loss prov. EUR 540mln vs. Exp. EUR 513mln. (Sources)

Daimler – Co.’s Mercedes-Benz January US vehicle sales rose 25.8% to 21,726 units, which are the highest January sales on record for the firm. (Sources)

Volkswagen – Co.’s Audi January US vehicle sales rose 19.7%. (Sources)

BMW – Co.’s January US vehicle sales rose 5.8% to 19,739 units. (Sources)

Lufthansa – Co.’s BMI unit signs a term sheet for the sale of BMI Baby which will allow discussions with other parties, with the transaction due this quarter according to the firm. (Sources)

Thyssenkrupp – Fitch affirmed the co.’s ‘BBB-‘ rating; outlook stable, following the Inoxum merger. In other news the co. said they may make small acquisitions in the elevator and technology unit field but they are unlikely to be above EUR 1bln. (RTRS/Handelsblatt)

Porsche – Co.’s January US vehicle sales rose 6% to 2,550 units. (Sources)

Munich Re – Co. says profit for Q4 totalled EUR 0.63bln. Co. anticipates that for 2012 it will be able to return to the result level achieved prior to 2011. Co. proposes dividend of EUR 6.25 per share for 2011. (Sources)

OTHER GERMAN

Qiagen - Co. CEO says could acquire in 2012. (Rheinische Post)

PAN EUROPEAN

Nokia – Co. Chairman Ollila says expects the co.’s transformation following the switch to Microsoft’s Windows 7 operating system is to take 18+ months in total and will impact 2012 earnings, stating it is ‘obvious’ the co. will be the third major player in the market. (Sources)

Fiat – Co. confirmed their investment at their Mirafiori plant and will build 280,000 cars a year at the plant according to the Co. CEO. (RTRS)

Spanish Banks - Spain’s new government will unveil the key details to clean up its financial sector this Friday. PM Rajoy is to present legislation that would force banks to set aside an additional EUR 50bln in 2012 to cover losses from souring loans. Merging banks would be given an extra year to raise these funds. (WSJ)

BBVA – Co. Q4 net EUR 139mln loss vs. Exp. EUR 88.2mln loss. Co. 2011 net EUR 3bln vs. Exp. EUR 3.05bln. Co. reports core capital at 10.3%. (Sources)

Banco Monti dei Paschi – Co. shareholders agree to a capital increase without consideration and conversion of savings shares into ordinary shares. (RTRS)

Teliasonera - Co. Q4 net SEK 4.97bln vs. Exp. SEK 5.2bln, Q4 sales SEK 27.1bln vs. Exp. SEK 27bln and Q4 pre-tax SEK 6.99bln vs. Exp. SEK 7.32bln. Co. says it completed first phase of KCell deal. (Sources)

SMI

Roche – Co. chief is open to talks with Illumina at any time to reach an amicable agreement and that an extension of the 24th February deadline is possible. (Basler Zeitung)

BROKER MOVES

BUY RIO TINTO ON CASH BACK POTENTIAL, CITI SAYS

IMPERIAL TOBACCO UPGRADED TO NEUTRAL FROM REDUCE AT NOMURA

SANOFI CUT TO SELL FROM NEUTRAL BY GOLDMAN SACHS